Want to take quizzes and track your credits?
lets you earn AMA PRA Category 1 CME Credit™ from a source you trust, JAMA Network. Find relevant articles, audio, video, and interactives, track your progress, and print certificates—all while deepening your knowledge of the topic at hand. Learn more
In this randomized, double-blind, placebo-controlled, dose-finding adaptive phase 2a/2b trial, treatment with human recombinant alkaline phosphatase did not improve kidney function among critically ill patients with sepsis-associated acute kidney injury (AKI). Peter Pickkers, MD, PhD, of Radboud University Nijmegen Medical Center, the Netherlands, presents findings from the STOP-AKI trial at the European Society of Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 24 in Paris. Used with permission.
You currently have no searches saved.